ND0612H

· NeuroDerm Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ND0612H, covering 2022-03-16 to 2022-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease [Phase 2]

See pricing